Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Iqvia Holdings Inc    IQV

IQVIA HOLDINGS INC (IQV)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 11/21 10:02:02 pm
104.36 USD   +0.44%
11/14 IQVIA : Mylan Launches Generic Clolar for Injection
11/07 IQVIA INSTITUTE : Impact of Digital Health Grows as Innovation, Evid..
11/06 QUINTILESIMS : is now IQVIA
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
11/15/2017 11/16/2017 11/17/2017 11/20/2017 11/21/2017 Date
103.84(c) 104.44(c) 104.46(c) 103.9(c) 104.36(c) Last
1 199 896 934 752 690 676 1 126 864 1 210 517 Volume
+0.35% +0.58% +0.02% -0.54% +0.44% Change
More quotes
Financials ($)
Sales 2017 8 037 M
EBIT 2017 1 644 M
Net income 2017 379 M
Debt 2017 7 750 M
Yield 2017 -
Sales 2018 8 527 M
EBIT 2018 1 819 M
Net income 2018 528 M
Debt 2018 7 246 M
Yield 2018 -
P/E ratio 2017 62,42
P/E ratio 2018 42,71
EV / Sales2017 3,70x
EV / Sales2018 3,42x
Capitalization 21 955 M
More Financials
Company
IQVIA Holdings, Inc. is a biotechnology company, which engages in healthcare development in the provision of professional services, information technology, and partnering solutions to the pharmaceutical services and healthcare industries.The company was founded by Dennis Gillings and Gary Koch in... 
More about the company
Surperformance© ratings of Iqvia Holdings Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on IQVIA HOLDINGS INC
11/18 IQVIA : WuXi AppTec elected by IQVIA Stem Cell Center to Serve as GMP Manufactur..
11/14 IQVIA : Mylan Launches Generic Clolar for Injection
11/07 IQVIA HOLDINGS INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal..
11/07 QUINTILES IMS : QuintilesIMS is now IQVIA
11/07 IQVIA INSTITUTE FOR HUMAN DATA SCIEN : Impact of Digital Health Grows as Innovat..
11/06 QUINTILESIMS : is now IQVIA
11/06 QUINTILESIMS : is now IQVIA
11/03 QUINTILES IMS : Heroes of all ages recognised at Pride of Reading awards
10/27 QUINTILES IMS : Management's Discussion and Analysis of Financial Condition and ..
10/26 QUINTILES IMS HOLDINGS, INC. : Results of Operations and Financial Condition, Fi..
More news
Sector news : Biotechnology & Medical Research - NEC
11/16 Recovery rally for European stocks leaves oil sector behind
11/13 Poor earnings updates keep European shares at seven-week low
11/13DJNOVARTIS : Vision Drug Shows Positive Results in Phase 3 Trials
11/03 Prosecutors search Metro offices in insider trading probe
11/01DJAs Experimental Treatments Grow, Families Face Tough Choices
More sector news : Biotechnology & Medical Research - NEC
News from SeekingAlpha
11/13 Premarket analyst action - healthcare
11/09 Premarket analyst action - healthcare
11/07 VALUATION DASHBOARD : Healthcare - Update
11/06 QuintilesIMS now IQVIA
10/27 Premarket analyst action - healthcare
Chart IQVIA HOLDINGS INC
Duration : Period :
Iqvia Holdings Inc Technical Analysis Chart | IQV | US74876Y1010 | 4-Traders
Technical analysis trends IQVIA HOLDINGS INC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 115 $
Spread / Average Target 11%
EPS Revisions
Managers
NameTitle
Ari Bousbib Chairman, President & Chief Executive Officer
Michael R. McDonnell Chief Financial Officer & Executive Vice President
Karl Guenault Chief Information Officer & Senior Vice President
Jonathan J. Coslet Director
Michael J. Evanisko Director
Sector and Competitors
1st jan.Capitalization (M$)
IQVIA HOLDINGS INC37.36%21 955
CELLTRION, INC.--.--%24 243
INCYTE CORPORATION5.19%20 882
LONZA GROUP59.15%19 698
ALNYLAM PHARMACEUTICALS, INC.240.57%12 601
SEATTLE GENETICS, INC.13.30%8 449